PATH insider files to sell 66,665 RSUs on NYSE for $859,978

Rhea-AI Filing Summary

UiPath, Inc. insider filing notifies a proposed sale of 66,665 common shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value listed as $859,978.50. The shares were acquired as Restricted Stock Units on 07/01/2023, with the filing indicating an approximate sale date of 10/06/2025. The filer disclosed prior automated 10b5-1 sales of 16,083 shares on 09/30/2025 generating gross proceeds of $241,262.69. The notice includes the standard signer representation that the seller has no undisclosed material adverse information.

Positive

• Shares were acquired as Restricted Stock Units on 07/01/2023, indicating prior compensation vesting
• Planned sale is brokered through Morgan Stanley Smith Barney, providing standard execution and disclosure
• Proposed sale size (66,665 shares) is small relative to 453,568,899 shares outstanding

Negative

• Insider sale of 66,665 shares could create modest downward pressure if combined with other sales
• Recent 10b5-1 sale on 09/30/2025 of 16,083 shares shows continuing insider liquidity

Insights

Corporate Insider / SEC Filings Specialist

TL;DR: An insider plans a Rule 144 sale of restricted stock units totaling 66,665 shares via Morgan Stanley.

The filing shows the securities originated as Restricted Stock Units acquired on 07/01/2023 and that the planned brokered sale is scheduled for 10/06/2025. The disclosure lists the broker and the aggregate market value as $859,978.50, which is required for transparency under Rule 144.

There is an explicit record of recent 10b5-1 systematic sales: 16,083 shares sold on 09/30/2025 for $241,262.69. Monitor settlement timing and any subsequent amendment filings that could alter the planned sale date or amounts within short reporting windows.

Equity Market Impact Analyst

TL;DR: The sale size is small relative to total outstanding shares and unlikely to be market-moving.

The notice shows 66,665 shares against 453,568,899 shares outstanding; that ratio indicates the proposed block represents a small fraction of float. The filing therefore signals routine insider liquidity rather than a material change in ownership.

Risk factors include timing clustering with other insider sales; the prior 10b5-1 sale of 16,083 shares on 09/30/2025 is a near-term data point to compare against future activity over the next weeks.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	66665	859978.50	453568899	10/06/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/01/2023	Restricted Stock Units	Issuer			66665	07/01/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BRAD C BRUBAKER One Vanderbilt Avenue, 60th Floor New York NY 10017	Common	09/30/2025	16083	241262.69

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by UiPath (PATH) disclose?

The filing discloses a proposed sale of 66,665 common shares through Morgan Stanley with an aggregate market value of $859,978.50, acquired as RSUs on 07/01/2023.

When is the proposed sale date listed in the Form 144 for PATH?

The filing lists an approximate date of sale of 10/06/2025.

Has the filer recently sold other UiPath shares?

Yes, the filing reports a 10b5-1 sale of 16,083 shares on 09/30/2025 generating gross proceeds of $241,262.69.

What was the acquisition type and date for the securities to be sold?

The securities were acquired as Restricted Stock Units on 07/01/2023.

Through which exchange will the UiPath shares be sold?

The filing indicates the shares are to be sold on the NYSE via Morgan Stanley Smith Barney.